The decision to refer back the matters related to lamivudine and montelukast are in an order observing that the Authority did not consider the Form V submitted by Cipla in March and May, 2022, before ...

Cipla, which also makes anti-allergic drug Cetirizine, said revenue from its drugs business in India rose 3.5%, while revenue from its North American market surged 39%. Cipla's profit growth had ...

In what could come as a shock for many, commonly used drugs such as Combiflam, D-cold Total, anti-allergic Cetrizine have failed ... Sun Pharma, Cipla and Glenmark Pharma are of “substandard ...

Cipla, which makes anti-allergic drug Cetirizine and generic versions of respiratory drugs Advair and Albuterol, had in July issued a clarification saying there is no information to disclose as ...

Cipla, which has a market cap of some $12 billion, is known for making the anti-allergy drug Cetirizine and generic versions of respiratory drugs Advair and Albuterol. It competes with global ...